Autologous CD19 CAR T products (tisagenlecleucel, axicabtagene ciloleucel, lisocabtagene maraleucel, brexucabtagene autoleucel) show high response rates across ALL and NHL, now including second-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results